Katja C Weisel (Katja Weisel)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Topics

Multiple Myeloma

Prognostic Factors

Top Venues

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Axel Benner, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Jan Dürig, Igor W Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Christoph Mann, Niels Weinhold, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe M Martens, Christian Kunz, Manfred Hensel, Andrea Seidel-Glätzer, Katja C Weisel, Hans J Salwender, Carsten Muller-Tidow, Marc-Steffen Raab, Hartmut Goldschmidt, Elias Karl Mai, Michael Hundemer
CD8 + CD28 - regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study. Leukemia 38 (7) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Axel Benner, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Jan Dürig, Igor W Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Christoph Mann, Niels Weinhold, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe M Martens, Christian Kunz, Manfred Hensel, Andrea Seidel-Glätzer, Katja C Weisel, Hans J Salwender, Carsten Muller-Tidow, Marc-Steffen Raab, Hartmut Goldschmidt, Elias Karl Mai, Michael Hundemer
CD8 + CD28 - regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study. Leukemia 38 (7) (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Axel Benner, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Jan Dürig, Igor W Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Christoph Mann, Niels Weinhold, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe M Martens, Christian Kunz, Manfred Hensel, Andrea Seidel-Glätzer, Katja C Weisel, Hans J Salwender, Carsten Muller-Tidow, Marc-Steffen Raab, Hartmut Goldschmidt, Elias Karl Mai, Michael Hundemer
CD8 + CD28 - regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study. Leukemia (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Axel Benner, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Jan Dürig, Igor W Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Christoph Mann, Niels Weinhold, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe M Martens, Christian Kunz, Manfred Hensel, Andrea Seidel-Glätzer, Katja C Weisel, Hans J Salwender, Carsten Muller-Tidow, Marc-Steffen Raab, Hartmut Goldschmidt, Elias Karl Mai, Michael Hundemer
CD8 + CD28 - regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study. Leukemia 38 (7) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Axel Benner, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Jan Dürig, Igor W Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Christoph Mann, Niels Weinhold, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe M Martens, Christian Kunz, Manfred Hensel, Andrea Seidel-Glätzer, Katja C Weisel, Hans J Salwender, Carsten Muller-Tidow, Marc-Steffen Raab, Hartmut Goldschmidt, Elias Karl Mai, Michael Hundemer
CD8 + CD28 - regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study. Leukemia 38 (7) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Axel Benner, Uta Bertsch, Britta Besemer, Mathias Hänel, Roland Fenk, Markus Munder, Jan Dürig, Igor W Blau, Stefanie Huhn, Dirk Hose, Anna Jauch, Christoph Mann, Niels Weinhold, Christof Scheid, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Peter Reimer, Rolf Mahlberg, Ullrich Graeven, Stephan Kremers, Uwe M Martens, Christian Kunz, Manfred Hensel, Andrea Seidel-Glätzer, Katja C Weisel, Hans J Salwender, Carsten Muller-Tidow, Marc-Steffen Raab, Hartmut Goldschmidt, Elias Karl Mai, Michael Hundemer
CD8 + CD28 - regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study. Leukemia 38 (7) (2024)
Charlotte Pawlyn, Schjesvold Fredrik, David A Cairns, L J Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos-Manteca, Jacob P Laubach, Katja C Weisel, Heinz Ludwig, Sundararajan Vincent Rajkumar, Pieter Sonneveld, Graham H Jackson, Gareth Morgan, Paul Gerard Richardson
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood cancer journal 14 (1) (2024)
Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee H Maclachlan, Michael A Durante, Benjamin T Diamond, Marios Papadimitriou, Faith E Davies, Eileen Mary Boyle, Brian A Walker, Malin L Hultcrantz, Ariosto Silva, Oliver Hampton, Jamie K Teer, Erin M Siegel, Niccolò Bolli, Graham H Jackson, Martin F Kaiser, Charlotte Pawlyn, Curly T C M Morris, Dickran Kazandjian, Caleb Stein, Marta Chesi, Peter Leif Bergsagel, Elias Karl Mai, Hartmut Goldschmidt, Katja C Weisel, Roland Fenk, Marc-Steffen Raab, Frits Van Rhee, Saad Z Usmani, Kenneth H Shain, Niels Weinhold, Gareth Morgan, Carl Ola Landgren
Genomic Classification and Individualized Prognosis in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Elias Karl Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Sonja Zweegman, Marc-Steffen Raab, Markus Munder, Lucia Pantani, Katia Mancuso, Peter Brossart, Meral Beksac, Igor W Blau, Jan Dürig, Britta Besemer, Roland Fenk, Peter Reimer, Bronno van der Holt, Mathias Hänel, Ivana von Metzler, Ullrich Graeven, Carsten Muller-Tidow, Mario Boccadoro, Christof Scheid, Meletios- Athanasios Dimopoulos, Jens Hillengass, Katja C Weisel, Michele Cavo, Pieter Sonneveld, Hartmut Goldschmidt
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients. Leukemia (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Lisa B Leypoldt, Diana Tichy, Britta Besemer, Mathias Hänel, Marc-Steffen Raab, Christoph Mann, Markus Munder, Hans Christian Reinhardt, Axel Nogai, Martin Görner, Yon-Dschun Ko, Maike de Wit, Hans J Salwender, Christof Scheid, Ullrich Graeven, Rudolf Peceny, Peter Staib, Annette Dieing, Hermann Einsele, Anna Jauch, Michael Hundemer, Manola Zago, Ema Požek, Axel Benner, Carsten Bokemeyer, Hartmut Goldschmidt, Katja C Weisel
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Maria-Victoria Mateos-Manteca, Katja C Weisel, Valerio De Stefano, Hartmut Goldschmidt, Michel Delforge, Mohamad Mohty, Michele Cavo, Ravi Vij, Joanne Lindsey-Hill, Dominik Dytfeld, Emanuele Angelucci, Aurore Perrot, Reuben Benjamin, Niels W C J van de Donk, Enrique M Ocio, Christof Scheid, Francesca Gay, Wilfried Roeloffzen, Paula Rodriguez-Otero, Annemiek Broijl, Anna Potamianou, Caline Sakabedoyan, Maria Semerjian, Sofia Keim, Vadim Strulev, Jordan M Schecter, Martin Vogel, Robert Wapenaar, Tonia Nesheiwat, Jesús San F Miguel, Pieter Sonneveld, Hermann Einsele, Philippe Moreau
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma. Leukemia 36 (5) (2022)
Thierry Facon, Gordon Cook, Saad Z Usmani, Cyrille Hulin, Shaji K Kumar, Torben Plesner, Cyrille Touzeau, Nizar J Bahlis, Supratik Basu, Hareth Nahi, Hartmut Goldschmidt, Hang Quach, Mohamad Mohty, Christopher P Venner, Katja C Weisel, Noopur Raje, Benjamin Hebraud, Karim Belhadj-Merzoug, Lotfi Benboubker, Olivier Decaux, Salomon Manier, Denis Caillot, Jon Ukropec, Huiling Pei, Rian Van Rampelbergh, Clarissa M Uhlar, Rachel Kobos, Sonja Zweegman
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA. Leukemia 36 (4) (2022)
Lisa B Leypoldt, Britta Besemer, Anne Marie Asemissen, Mathias Hänel, Igor Wolfgang Blau, Martin Görner, Yon-Dschun Ko, Hans Christian Reinhardt, Peter Staib, Christoph Mann, Raphael Lutz, Markus Munder, Ullrich Graeven, Rudolf Peceny, Hans J Salwender, Anna Jauch, Manola Zago, Axel Benner, Diana Tichy, Carsten Bokemeyer, Hartmut Goldschmidt, Katja C Weisel
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial. Leukemia (2021)
Hans J Salwender, Ahmet Elmaagacli, Maximilian Merz, Kaya Miah, Axel Benner, Mathias Haenel, Christian Jehn, Elias Karl Mai, Uta Bertsch, Igor W Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Anna Jauch, Marc S Raab, Steffen P Luntz, Britta Besemer, Markus Munder, Peter Brossart, Stephan Fuhrmann, Hans-Walter Lindemann, Katja C Weisel, Jan Duerig, Hartmut Goldschmidt
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. Leukemia 35 (10) (2021)
Evangelos Terpos, Joseph Mikhael, Roman Hájek, Ajai Chari, Sonja Zweegman, Hans C Lee, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Karthik Ramasamy, Martin F Kaiser, Gordon Cook, Katja C Weisel, Caitlin L Costello, Jennifer Elliott, Antonio Palumbo, Saad Z Usmani
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood cancer journal 11 (2) (2021)
Marc-Andrea Baertsch, Elias Karl Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Markus Munder, Stephan Fuhrmann, Ulrich Dührsen, Peter Brossart, Kai Neben, Jana Schlenzka, Christina Kunz, Marc S Raab, Jens Hillengaß, Anna Jauch, Anja Seckinger, Dirk Hose, Steffen Luntz, Pieter Sonneveld, Henk Lokhorst, Hans Martin, Martin Goerner, Martin Hoffmann, Hans-Walter Lindemann, Helga Bernhard, Igor W Blau, Christof Scheid, Britta Besemer, Katja C Weisel, Mathias Hänel, Jan Dürig, Hartmut Goldschmidt, null null
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma. Blood cancer journal 11 (1) (2021)
Katja C Weisel, Maria-Victoria Mateos-Manteca, Francesca Gay, Michel Delforge, Curly T C M Morris, Zsolt Szabo, Renaud Desgraz, Lucy DeCosta, Philippe Moreau
Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR. Leukemia 35 (6) (2020)